Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant HIPEC for Locally Advanced Gastric Cancer
NCT02672865Phase 1Completed
- Sponsor
- Loma Linda University
- Start
- Feb 2016
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of mitomycin c and cisplatin in gastric cancer (GC), sponsored by Loma Linda University. Primary endpoint: Post Operative Complications at 90 days. Started Feb 2016; status: completed.
02
Drugs
mitomycin ccisplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02672865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02672865.